Cathie Wood Goes Bargain Hunting. 2 Stocks She Bought This Week.
Cathie Wood is known for her investments in disruptive technologies that are changing or have the potential to change the way things are done. She's built a solid reputation as a stock picker, aiming to beat the market over the long term by buying innovative companies with a vision and the technology to reach their goals. In many cases, the chief executive officer of Ark Invest even buys shares of a company when they're wallowing in the doldrums because she's confident about that company's long-term prospects.
That's the case with two healthcare stocks at the moment, and Wood scooped up shares of both, adding to existing positions this week. I'm talking about telemedicine leader Teladoc Health (NYSE: TDOC) and gene editing company Intellia Therapeutics (NASDAQ: NTLA).
Both of these stocks have dropped in the double digits over the past year, but Wood still sees a bright future for these players. They are among the top 20 holdings in her flagship fund Ark Innovation and her healthcare fund Ark Genomic Revolution.
Source Fool.com
Intellia Therapeutics Inc Aktie
Die Intellia Therapeutics Inc Aktie erhält starke Unterstützung mit mehreren Buy- und keiner Sell-Einschätzung.
Das Kursziel von 60 €, festgelegt von der Community für Intellia Therapeutics Inc, zeigt ein Potenzial von 170.03%, was einer Verdopplung des aktuellen Kurses entspricht.
